Support Your Metabolism with Clinically-Studied Ingredients

Mitolyn — 6 plant-based nutrients to boost mitochondrial health, energy & natural fat burning.

★★★★★ 127,000+ customers · 90-day money-back guarantee

Anil Chandraker, MBCHB

Nephrology Worcester, MA Male

NPI: 1972569176

Total Payments

$113,459

2024 Payments

$34,364

Companies

Transactions

Medicare Patients

1,265

Medicare Billing

$250,717

Payment Breakdown by Category

Consulting$108,412 (95.6%)

Other$2,640 (2.3%)

Travel$1,222 (1.1%)

Food & Beverage$1,076 (0.9%)

Education$109.20 (0.1%)

Payments by Nature

Nature of Payment	Amount	Transactions	Share
Consulting Fee	$108,412	27	95.6%
Honoraria	$2,640	1	2.3%
Travel and Lodging	$1,222	7	1.1%
Food and Beverage	$1,076	17	0.9%
Education	$109.20	3	0.1%

Top Paying Companies

Company	Total	Records	Latest Year
VERTEX PHARMACEUTICALS INCORPORATED	$73,274	23	$0 (2024)
Immucor, Inc.	$11,048	2	$0 (2023)
Shire North American Group Inc	$6,825	3	$0 (2019)
SANOFI-AVENTIS U.S. LLC	$6,767	3	$0 (2023)
GENZYME CORPORATION	$4,471	7	$0 (2018)
Horizon Therapeutics plc	$2,929	6	$0 (2023)
Alnylam Pharmaceuticals Inc.	$2,700	1	$0 (2021)
NOVARTIS PHARMACEUTICALS CORPORATION	$2,025	1	$0 (2023)
Chugai Pharmaceutical Co., Ltd.	$1,075	3	$0 (2018)
Takeda Pharmaceuticals U.S.A., Inc.	$1,050	1	$0 (2020)

Payment History by Year

Year	Amount	Transactions	Top Company
2024	$34,364	17	VERTEX PHARMACEUTICALS INCORPORATED ($34,154)
2023	$24,433	14	Vertex Pharmaceuticals Incorporated ($15,485)
2022	$26,490	5	Vertex Pharmaceuticals Incorporated ($23,635)
2021	$13,700	2	Immucor, Inc. ($11,000)
2020	$1,050	1	Takeda Pharmaceuticals U.S.A., Inc. ($1,050)
2019	$1,050	1	Shire North American Group Inc ($1,050)
2018	$11,321	12	Shire North American Group Inc ($5,775)
2017	$1,051	3	T2 Biosystems, Inc. ($1,000)

All Payment Transactions

55 individual payment records from CMS Open Payments — Page 1 of 3

Date	Company	Product	Nature	Form	Amount	Type
11/13/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Food and Beverage	In-kind items and services	$47.50	General
11/13/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Food and Beverage	In-kind items and services	$31.45	General
11/13/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Food and Beverage	In-kind items and services	$26.00	General
10/26/2024	Pierre Fabre Pharmaceuticals, Inc.	HEMANGEOL (Drug)	Travel and Lodging	In-kind items and services	$210.90	General
Category: PEDIATRIC DERMATOLOGY
09/04/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Food and Beverage	In-kind items and services	$75.10	General
09/04/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Food and Beverage	In-kind items and services	$60.00	General
06/26/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Consulting Fee	Cash or cash equivalent	$1,215.50	General
06/12/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Consulting Fee	Cash or cash equivalent	$4,207.50	General
06/12/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Travel and Lodging	In-kind items and services	$313.00	General
04/29/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Consulting Fee	Cash or cash equivalent	$3,260.00	General
04/29/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Consulting Fee	Cash or cash equivalent	$2,852.50	General
04/29/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Travel and Lodging	In-kind items and services	$45.00	General
02/28/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Consulting Fee	Cash or cash equivalent	$4,890.00	General
02/28/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Consulting Fee	Cash or cash equivalent	$3,260.00	General
02/28/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Travel and Lodging	In-kind items and services	$15.00	General
01/17/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Consulting Fee	Cash or cash equivalent	$7,335.00	General
01/17/2024	VERTEX PHARMACEUTICALS INCORPORATED	—	Consulting Fee	Cash or cash equivalent	$6,520.00	General
11/15/2023	Vertex Pharmaceuticals Incorporated	—	Consulting Fee	Cash or cash equivalent	$8,150.00	General
11/15/2023	Vertex Pharmaceuticals Incorporated	—	Consulting Fee	Cash or cash equivalent	$6,520.00	General
11/02/2023	Vertex Pharmaceuticals Incorporated	—	Consulting Fee	Cash or cash equivalent	$815.00	General
10/13/2023	SANOFI-AVENTIS U.S. LLC	—	Consulting Fee	Cash or cash equivalent	$3,750.00	General
10/13/2023	SANOFI-AVENTIS U.S. LLC	—	Food and Beverage	In-kind items and services	$161.72	General
10/06/2023	Horizon Therapeutics plc	KRYSTEXXA (Biological)	Honoraria	Cash or cash equivalent	$2,640.00	General
Category: KRYSTEXXA
10/06/2023	Horizon Therapeutics plc	KRYSTEXXA (Biological)	Food and Beverage	Cash or cash equivalent	$84.84	General
Category: KRYSTEXXA
10/06/2023	Horizon Therapeutics plc	KRYSTEXXA (Biological)	Food and Beverage	Cash or cash equivalent	$64.65	General
Category: KRYSTEXXA

1 2 3 »

Medicare Billing by Year

Year	Procedures	Beneficiaries	Services	Submitted	Medicare Paid
2023	8	295	766	$309,873	$64,718
2022	9	302	721	$302,012	$62,605
2021	10	367	842	$343,792	$71,648
2020	7	301	662	$243,076	$51,746

Total Patients

1,265

Total Services

2,991

Medicare Billing

$250,717

Procedure Codes

All Medicare Procedures & Services

34 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS	Description	Setting	Year	Patients	Services	Charges	Medicare Paid	Ratio
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	Facility	2023	49	233	$99,682	$23,367	23.4%
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	Facility	2023	57	204	$61,160	$13,107	21.4%
99214	Established patient office or other outpatient visit, 30-39 minutes	Facility	2023	73	127	$51,326	$9,917	19.3%
99215	Established patient office or other outpatient visit, 40-54 minutes	Facility	2023	43	71	$42,529	$7,726	18.2%
90945	Dialysis procedure including 1 evaluation	Facility	2023	12	57	$20,364	$4,090	20.1%
99238	Hospital discharge day management, 30 minutes or less	Facility	2023	34	42	$12,660	$2,693	21.3%
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	Facility	2023	15	18	$14,490	$2,496	17.2%
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	Facility	2023	12	14	$7,662	$1,321	17.2%
99233	Follow-up hospital inpatient care per day, typically 35 minutes	Facility	2022	61	365	$149,698	$31,916	21.3%
99214	Established patient office or other outpatient visit, 30-39 minutes	Facility	2022	91	166	$65,925	$12,770	19.4%
99215	Established patient office or other outpatient visit, 40-54 minutes	Facility	2022	37	51	$30,053	$6,177	20.6%
99223	Initial hospital inpatient care per day, typically 70 minutes	Facility	2022	18	19	$15,087	$3,208	21.3%
99222	Initial hospital inpatient care per day, typically 50 minutes	Facility	2022	21	21	$11,305	$2,421	21.4%
99232	Follow-up hospital inpatient care per day, typically 25 minutes	Facility	2022	15	33	$9,549	$1,997	20.9%
99238	Hospital discharge day management, 30 minutes or less	Facility	2022	25	32	$9,256	$1,983	21.4%
99239	Hospital discharge day management, more than 30 minutes	Facility	2022	13	13	$5,499	$1,183	21.5%
99213	Established patient office or other outpatient visit, 20-29 minutes	Facility	2022	21	21	$5,640	$949.65	16.8%
99233	Subsequent hospital inpatient care, typically 35 minutes per day	Facility	2021	80	324	$136,098	$28,762	21.1%
99214	Established patient outpatient visit, total time 30-39 minutes	Facility	2021	96	250	$85,606	$20,348	23.8%
90945	Dialysis procedure including one evaluation	Facility	2021	19	69	$24,455	$5,237	21.4%
99222	Initial hospital inpatient care, typically 50 minutes per day	Facility	2021	31	35	$19,401	$4,065	21.0%
99238	Hospital discharge day management, 30 minutes or less	Facility	2021	49	58	$17,205	$3,637	21.1%
99215	Established patient outpatient visit, total time 40-54 minutes	Facility	2021	24	27	$12,312	$2,796	22.7%
99223	Initial hospital inpatient care, typically 70 minutes per day	Facility	2021	11	11	$8,895	$1,907	21.4%
50200	Needle biopsy of kidney, accessed through the skin	Facility	2021	16	16	$26,544	$1,785	6.7%

1 2 »

About Anil Chandraker, MBCHB

Anil Chandraker, MBCHB is a Nephrology healthcare provider based in Worcester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972569176.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anil Chandraker, MBCHB has received a total of $113,459 in payments from pharmaceutical and medical device companies, with $34,364 received in 2024. These payments were reported across 55 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($108,412).

As a Medicare-enrolled provider, Chandraker has provided services to 1,265 Medicare beneficiaries, totaling 2,991 services with total Medicare billing of $250,717. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.

16,000 Woodworking Plans

Step-by-step blueprints for any project. Beginner to expert.

Detailed schematics Cutting lists & materials Lifetime access — $67

★★★★★ 60-day guarantee

Get Instant Access

Practice Information

Specialty Nephrology
Location Worcester, MA
Active Since 04/25/2006
Last Updated 12/18/2023
Taxonomy Code 207RN0300X
Entity Type Individual
NPI Number 1972569176

Products in Payments

THYMOGLOBULIN (Drug) $4,471
KRYSTEXXA (Biological) $2,929
OXLUMO (Drug) $2,700
CellCept (Drug) $1,075
T2Dx (Device) $1,000
HEMANGEOL (Drug) $210.90
Envarsus XR (Drug) $51.29
ENVARSUS (Drug) $34.10

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.